hexanitrohexaazaisowurzitane: photolytic decomposition of above cpd yields nitrogen dioxide radicals; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
CL-20 : A polycyclic cage that is hexaazaisowurtzitane in which all six amino hydrogens are replaced by nitro groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 9889323 |
| CHEBI ID | 77327 |
| SCHEMBL ID | 272402 |
| MeSH ID | M0222444 |
| Synonym |
|---|
| unii-rqm82x0cl7 |
| lx 19 |
| rx 39ac |
| 135285-90-4 |
| rx 39ab |
| hexanitrohexaazaisowurzitane |
| octahydro-1,3,4,7,8,10-hexanitro-5,2,6-(iminomethenimino)-1h-imidazo(4,5-b)pyrazine |
| 5,2,6-(iminomethenimino)-1h-imidazo(4,5-b)pyrazine, octahydro-1,3,4,7,8,10-hexanitro- |
| hexanitrohexaazaisowurtzitane |
| rqm82x0cl7 , |
| hniw |
| cl-20 |
| SCHEMBL272402 |
| CHEBI:77327 |
| 1,3,4,7,8,10-hexanitrooctahydro-1h-5,2,6-(epiminomethanetriylimino)imidazo[4,5-b]pyrazine |
| 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaaza-tetracyclo-[5.5.0.05,9.03,11]-dodecane |
| NDYLCHGXSQOGMS-UHFFFAOYSA-N |
| DTXSID90873482 |
| Q413926 |
| 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexazatetracyclo[5.5.0.03,11.05,9]dodecane |
| 5,2,6-(iminomethenimino)-1h-imidazo[4,5-b]pyrazine, octahydro-1,3,4,7,8,10-hexanitro- |
| Role | Description |
|---|---|
| explosive | A substance capable of undergoing rapid and highly exothermic decomposition. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Class | Description |
|---|---|
| N-nitro compound | A compound having the nitro group (-NO2) attached to a nitrogen atom. |
| polycyclic cage | A polycyclic compound having the shape of a cage. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||